MedPath
FDA Approval

TECHNETIUM TC 99M SESTAMIBI

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
October 22, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Jubilant Draximage (USA) Inc.

080981460

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Jubilant HollisterStier General Partnership

Jubilant Draximage (USA) Inc.

Jubilant Draximage (USA) Inc.

246762764

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

TECHNETIUM TC 99M SESTAMIBI

Product Details

NDC Product Code
45548-141
Application Number
ANDA078806
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
August 13, 2017
Code: 971Z4W1S09Class: ACTIRQuantity: 1 mg in 1 mL
TRISODIUM CITRATE DIHYDRATEInactive
Code: B22547B95KClass: IACTQuantity: 2.6 mg in 1 mL
Stannous ChlorideInactive
Code: 1BQV3749L5Class: IACTQuantity: 0.075 mg in 1 mL
Cysteine HydrochlorideInactive
Code: ZT934N0X4WClass: IACTQuantity: 1 mg in 1 mL
MannitolInactive
Code: 3OWL53L36AClass: IACTQuantity: 20 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath